Exelixis, Inc. (EXEL) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Exelixis financial statements at a glance

Exelixis reported revenue of $2.32 billion for fiscal year 2025 (ended December 31, 2025), up 7.0% from fiscal year 2024. Net income was $782.57 million, a net margin of 33.7%, and diluted earnings per share were $2.78.

At the end of fiscal year 2025 it had total assets of $2.84 billion, total liabilities of $683.10 million and shareholders' equity of $2.16 billion, with cash and short-term investments of $1.06 billion and total debt of $173.04 million.

Its operations brought in $884.27 million of cash; capital spending was $39.93 million, leaving free cash flow of $844.34 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

EXEL logo

Exelixis, Inc.

EXELUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
2.32B
Prev Year: 2.17B
YoY: +7.0%
Operating Revenue
3.21B
Prev Year: 2.88B
YoY: +11.5%
Total Unusual Items
-20.51M
Prev Year: -85.33M
YoY: +76.0%
Total Unusual Items Excluding Goodwill
-20.51M
Prev Year: -85.33M
YoY: +76.0%
Total Expenses
1.43B
Prev Year: 1.48B
YoY: -3.5%
Total Operating Income as Reported
872.19M
Prev Year: 604.62M
YoY: +44.3%
Diluted NI Available to Com Stockholders
782.57M
Prev Year: 521.27M
YoY: +50.1%
Special Income Charges
-20.51M
Prev Year: -85.33M
YoY: +76.0%
Restructuring and Mergers Acquisition
20.51M
Prev Year: 20.94M
YoY: -2.1%
Salaries and Wages
72.19M
Prev Year: 63.17M
YoY: +14.3%
Cost of Revenue
83.70M
Prev Year: 76.22M
YoY: +9.8%
Gross Profit
2.24B
Prev Year: 2.09B
YoY: +6.9%
Operating Expense
1.34B
Prev Year: 1.40B
YoY: -4.2%
Selling General and Administrative
518.73M
Prev Year: 492.13M
YoY: +5.4%
General and Administrative Expense
518.73M
Prev Year: 492.13M
YoY: +5.4%
Other General and Administrative
446.54M
Prev Year: 428.96M
YoY: +4.1%
Research and Development
825.00M
Prev Year: 910.41M
YoY: -9.4%
Operating Income
892.70M
Prev Year: 689.95M
YoY: +29.4%
Net Non Operating Interest Income Expense
69.21M
Prev Year: 77.16M
YoY: -10.3%
Non-operating Interest Income
69.21M
Prev Year: 77.16M
YoY: -10.3%
Other Income Expense
-20.71M
Prev Year: -85.47M
YoY: +75.8%
Other Non-operating Income (expense)
-198.0K
Prev Year: -133.0K
YoY: -48.9%
Pre-tax Income
941.21M
Prev Year: 681.64M
YoY: +38.1%
Provision for Income Taxes
158.64M
Prev Year: 160.37M
YoY: -1.1%
Net Income Common Stockholders
782.57M
Prev Year: 521.27M
YoY: +50.1%
Net Income
782.57M
Prev Year: 521.27M
YoY: +50.1%
Net Income Including Non-Controlling Interests
782.57M
Prev Year: 521.27M
YoY: +50.1%
Net Income from Continuing Operations
782.57M
Prev Year: 521.27M
YoY: +50.1%
Basic EPS
2.88
Prev Year: 1.8
YoY: +60.0%
Diluted EPS
2.78
Prev Year: 1.76
YoY: +58.0%
Weighted Average Shares (basic)
271.57M
Prev Year: 290.03M
YoY: -6.4%
Weighted Average Shares (diluted)
281.86M
Prev Year: 296.13M
YoY: -4.8%
Net Income from Continuing and Discontinued Operation
782.57M
Prev Year: 521.27M
YoY: +50.1%
Normalized Income
799.61M
Prev Year: 586.55M
YoY: +36.3%
Interest Income
69.21M
Prev Year: 77.16M
YoY: -10.3%
Net Interest Income
69.21M
Prev Year: 77.16M
YoY: -10.3%
EBIT
892.70M
Prev Year: 689.95M
YoY: +29.4%
EBITDA
921.76M
Prev Year: 718.75M
YoY: +28.2%
Reconciled Cost of Revenue
83.70M
Prev Year: 76.22M
YoY: +9.8%
Reconciled Depreciation
29.05M
Prev Year: 28.80M
YoY: +0.9%
Net Income from Continuing Operation Net Minority Interest
782.57M
Prev Year: 521.27M
YoY: +50.1%
Normalized EBITDA
942.27M
Prev Year: 804.08M
YoY: +17.2%
Tax Rate for Calcs
0.169
Prev Year: 0.235
YoY: -28.1%
Tax Effect of Unusual Items
-3.47M
Prev Year: -20.05M
YoY: +82.7%
Values in USD

Exelixis key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$2.3B$2.2B$1.8B$1.6B$1.4B
Gross profit$2.2B$2.1B$1.8B$1.6B$1.4B
Operating income$892.7M$689.9M$170.9M$201.5M$286.7M
Net income$782.6M$521.3M$207.8M$182.3M$231.1M
Diluted EPS$2.78$1.76$0.65$0.56$0.72
Total assets$2.8B$2.9B$2.9B$3.1B$2.6B
Total liabilities$683.1M$703.5M$678.4M$583.1M$405.6M
Shareholders' equity$2.2B$2.2B$2.3B$2.5B$2.2B
Cash and short-term investments$1.1B$1.1B$995.3M$1.3B$1.5B
Total debt$173.0M$190.8M$189.9M$190.2M$51.3M
Operating cash flow$884.3M$700.0M$333.3M$362.6M$400.8M
Capital spending$39.9M$66.2M$163.0M$138.5M$64.2M
Free cash flow$844.3M$633.8M$170.4M$224.2M$336.6M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.

Questions and answers

What was Exelixis's revenue in fiscal year 2025?

$2.32 billion, up 7.0% from $2.17 billion in fiscal year 2024.

How much profit does Exelixis make?

Exelixis reported net income of $782.57 million for fiscal year 2025 (33.7% of revenue); operating income was $892.70 million.

How much cash and debt does Exelixis have?

At the end of fiscal year 2025: cash and short-term investments of $1.06 billion and total debt of $173.04 million.

What is Exelixis's free cash flow?

$844.34 million in fiscal year 2025 (operating cash flow of $884.27 million minus capital spending of $39.93 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube